References: Alba, M., Fintini, D., Sagazio, A., Lawrence, B., Castaigne, J
Would love to hear your thoughts #Pharma #PharmaIndustry #Healthcare #GLP1 #Semaglutide #DiabetesCare #ObesityCare #IndianPharma #PharmaStrategy #HealthcareInnovation #ChronicCare #MarketTrends #BusinessStrategy #PharmaMarketing #FutureOfHealthcare To view or add a comment, sign in The last week in Indian Pharma was all about semaglutide
Do GLP-1s have to be refrigerated after opening
If hemorrhoids developed after starting semaglutide
Abstract Aim We aimed to compare cardiovascular outcomes of patients with type 2 diabetes (T2D) who initiated GLP-1 receptor agonists (GLP-1RA) or basal insulin (BI) under routine care
Information can change: Always check the official websites of any companies mentioned for the most up-to-date details on their services